Balance Sheet Daikin Industries,Ltd.

Equities

6367

JP3481800005

Electrical Components & Equipment

Delayed Japan Exchange Other stock markets 20:26:29 2026-03-05 EST			5-day change	1st Jan Change
19,595.00 ^JPY	-0.03%		-1.38%	-2.19%

03-04	Jefferies Adjusts Daikin Industries' Price Target to 23,100 Yen From 24,800 Yen, Keeps at Buy	MT
03-04	Japanese Shares Slide As BOJ Flags Further Rate Hikes On Middle East Concerns	MT

a7060eb38db5f2571f6f9284.1xhGCHsPWBHHAGo5l1h_nu2rhIZJv61mvsGxjIepW84.vV0vUT9cLVqKLSxQ2xopp7jx1rcR9_gNybPn1sXvIaC2SBlEHH9sJuozCQ

Published financial data: DAIKIN INDUSTRIES,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	2,493B	3,109B	3,982B	4,395B	4,752B
Total Revenues	2,493B	3,109B	3,982B	4,395B	4,752B
Cost of Goods Sold, Total	1,629B	2,052B	2,650B	2,886B	3,126B
Gross Profit	864B	1,057B	1,331B	1,510B	1,627B
Selling General & Admin Expenses, Total	441B	528B	692B	800B	881B
Provision for Bad Debts	2.22B	2.63B	3.41B	3.95B	893M
R&D Expenses	53.82B	64.7B	83.2B	103B	114B
Depreciation & Amortization - (IS)	36.18B	40.95B	51.18B	60.83B	67.22B
Amortization of Goodwill and Intangible Assets - (IS)	30.05B	32.68B	39.5B	45.58B	48.57B
Other Operating Expenses	62.26B	72.44B	85.53B	105B	113B
Other Operating Expenses, Total	626B	741B	954B	1,118B	1,225B
Operating Income	239B	316B	377B	392B	402B
Interest Expense, Total	-8.79B	-8.82B	-20.29B	-44.9B	-43.03B
Interest And Investment Income	10.7B	12.89B	16.98B	21.12B	23.96B
Net Interest Expenses	1.9B	4.06B	-3.31B	-23.78B	-19.08B
Income (Loss) On Equity Invest.	7M	1.4B	1.7B	1.6B	2.18B
Currency Exchange Gains (Loss)	547M	4.49B	3.8B	-1.11B	-9.16B
Other Non Operating Income (Expenses)	-835M	1.19B	-12.97B	-14.36B	-9.16B
EBT, Excl. Unusual Items	240B	327B	366B	354B	366B
Gain (Loss) On Sale Of Investments	-164M	5.65B	15.83B	45.85B	12.78B
Gain (Loss) On Sale Of Assets	-1.32B	-335M	-1.05B	-2.8B	-940M
Asset Writedown	-225M	-3.67B	-8.58B	-12.24B	-
Other Unusual Items	6M	-1.09B	937M	-1M	-2.19B
EBT, Incl. Unusual Items	239B	328B	373B	385B	376B
Income Tax Expense	75.8B	103B	108B	115B	101B
Earnings From Continuing Operations	163B	225B	265B	270B	275B
Net Income to Company	163B	225B	265B	270B	275B
Minority Interest	-6.5B	-7.56B	-7.69B	-9.52B	-10.69B
Net Income - (IS)	156B	218B	258B	260B	265B
Net Income to Common Incl Extra Items	156B	218B	258B	260B	265B
Net Income to Common Excl. Extra Items	156B	218B	258B	260B	265B
Per Share Items
Net EPS - Basic	533.97	743.88	880.58	889.21	904.27
Basic EPS - Continuing Operations	533.97	743.88	880.58	889.21	904.27
Basic Weighted Average Shares Outstanding	293M	293M	293M	293M	293M
Net EPS - Diluted	533.66	743.46	880.05	888.64	903.65
Diluted EPS - Continuing Operations	533.66	743.46	880.05	888.64	903.65
Diluted Weighted Average Shares Outstanding	293M	293M	293M	293M	293M
Normalized Basic EPS	490.94	673.55	755.75	724.3	745.73
Normalized Diluted EPS	490.66	673.16	755.29	723.83	745.22
Dividend Per Share	160	200	240	250	280
Payout Ratio	29.9	22.85	23.85	29.23	34.82
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	372B	464B	559B	608B	648B
EBITA	269B	349B	417B	438B	450B
EBIT	239B	316B	377B	392B	402B
Effective Tax Rate - (Ratio)	31.78	31.33	28.91	29.97	26.76
Normalized Net Income	144B	197B	221B	212B	218B
Non-Cash Pension Expense	-537M	-2.24B	-1.23B	-309M	1.26B
Supplemental Operating Expense Items
Advertising Expense	50.4B	59.87B	71.33B	80.37B	84.15B
Selling and Marketing Expenses	114B	137B	167B	182B	191B
Research And Development Expense From Footnotes	71.74B	81.54B	102B	122B	136B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	736B	818B	618B	738B	803B
Total Cash And Short Term Investments	736B	818B	618B	738B	803B
Accounts Receivable, Total	455B	578B	687B	793B	834B
Total Receivables	455B	578B	687B	793B	834B
Inventory	469B	671B	993B	1,048B	1,053B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	72.61B	98.4B	129B	148B	164B
Total Current Assets	1,733B	2,166B	2,427B	2,727B	2,854B
Net Property Plant And Equipment	647B	743B	901B	1,135B	1,279B
Long-term Investments	283B	295B	275B	281B	294B
Goodwill	269B	270B	304B	307B	266B
Other Intangibles, Total	274B	308B	354B	377B	372B
Loans Receivable Long-Term	1.15B	668M	744M	1.38B	1.8B
Deferred Tax Assets Long-Term	31.69B	41.34B	41.01B	52.25B	66.33B
Other Long-Term Assets, Total	1M	1M	2M	2M	2M
Total Assets	3,240B	3,824B	4,304B	4,880B	5,133B
Liabilities
Accounts Payable, Total	230B	303B	353B	326B	362B
Accrued Expenses, Total	154B	206B	248B	273B	283B
Short-term Borrowings	40.75B	97.38B	373B	414B	324B
Current Portion of Long-Term Debt	76.28B	365B	73.9B	73.45B	73.18B
Current Portion of Leases	20.64B	25.88B	30.44B	40.09B	42.79B
Current Income Taxes Payable	20.76B	36.74B	37.73B	41.26B	47.19B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	224B	273B	334B	399B	410B
Total Current Liabilities	766B	1,306B	1,449B	1,567B	1,543B
Long-Term Debt	549B	261B	314B	325B	415B
Long-Term Leases	64.74B	76.51B	96.6B	116B	132B
Pension & Other Post Retirement Benefits	14.54B	16.12B	18.18B	19.91B	21.76B
Deferred Tax Liability Non Current	119B	121B	104B	110B	93.29B
Other Non Current Liabilities	28.5B	35.15B	42.79B	54.81B	61.94B
Total Liabilities	1,541B	1,816B	2,025B	2,193B	2,267B
Common Stock, Total	85.03B	85.03B	85.03B	85.03B	85.03B
Additional Paid In Capital	84.21B	83.83B	79.48B	78.01B	87.3B
Retained Earnings	1,364B	1,530B	1,712B	1,896B	2,068B
Treasury Stock	-2.01B	-1.85B	-1.68B	-1.52B	-1.35B
Comprehensive Income and Other	137B	275B	363B	584B	566B
Total Common Equity	1,668B	1,972B	2,238B	2,641B	2,805B
Minority Interest	30.79B	35.88B	40.95B	45.99B	61.2B
Total Equity	1,698B	2,008B	2,279B	2,687B	2,867B
Total Liabilities And Equity	3,240B	3,824B	4,304B	4,880B	5,133B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	293M	293M	293M	293M	293M
ECS Total Common Shares Outstanding	293M	293M	293M	293M	293M
Book Value / Share	5.7K	6.74K	7.65K	9.02K	9.58K
Tangible Book Value	1,125B	1,394B	1,580B	1,958B	2,168B
Tangible Book Value Per Share	3.84K	4.76K	5.4K	6.69K	7.4K
Total Debt	751B	825B	888B	968B	987B
Net Debt	15.11B	7.2B	270B	230B	184B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-5.42B	-10.22B	-5.01B	-7.51B	-15.04B
Minority Interest, Total (Incl. Fin. Div)	30.79B	35.88B	40.95B	45.99B	61.2B
Inventories - Raw Materials, Total	108B	176B	260B	275B	271B
Inventories - Work In Process, Total	34.77B	44.93B	65.52B	75.93B	72.19B
Inventories - Finished Goods, Total	327B	451B	668B	696B	709B
Full Time Employees	84.87K	88.7K	96.34K	98.16K	104K
Accumulated Allowance for Doubtful Accounts (Supple)	13.07B	16.93B	19.18B	22.54B	22.4B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	239B	328B	373B	385B	376B
Depreciation & Amortization - CF	104B	115B	143B	170B	197B
Amortization of Goodwill and Intangible Assets - (CF)	30.05B	32.68B	39.5B	45.58B	48.57B
Depreciation & Amortization, Total	134B	148B	182B	216B	246B
(Gain) Loss From Sale Of Asset	1.43B	4.25B	9.62B	15.08B	1.2B
(Gain) Loss on Sale of Investments - (CF)	159M	-5.44B	-15.74B	-45.85B	-11.11B
(Income) Loss On Equity Investments - (CF)	-7M	-1.4B	-1.7B	-1.6B	-2.18B
Other Operating Activities, Total	-68.27B	-96.64B	-127B	-136B	-129B
Change In Accounts Receivable	-1.02B	-76.68B	-61.81B	-36.09B	-40.09B
Change In Inventories	-7.75B	-151B	-268B	36.53B	-10.92B
Change In Accounts Payable	51.1B	89.72B	50.89B	-52.85B	36.31B
Change in Other Net Operating Assets	26.91B	6.17B	16.21B	19.54B	47.67B
Cash from Operations	375B	245B	159B	400B	514B
Capital Expenditure	-105B	-114B	-175B	-243B	-246B
Sale of Property, Plant, and Equipment	4.72B	5.34B	6.86B	3.14B	6.63B
Cash Acquisitions	-28.57B	-42.73B	-106B	-11.52B	-25.25B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-19.18B	-6.9B	69.78B	38.61B	-39.99B
Other Investing Activities, Total	-11.67B	-22.4B	-25.29B	-14.79B	-32.81B
Cash from Investing	-160B	-181B	-230B	-227B	-337B
Short Term Debt Issued, Total	-	57.05B	270B	17.87B	-
Long-Term Debt Issued, Total	293B	68.37B	116B	60.48B	166B
Total Debt Issued	293B	125B	386B	78.35B	166B
Short Term Debt Repaid, Total	-9.25B	-	-	-	-96.69B
Long-Term Debt Repaid, Total	-106B	-89.58B	-387B	-78.29B	-76.09B
Total Debt Repaid	-115B	-89.58B	-387B	-78.29B	-173B
Common Dividends Paid	-46.72B	-49.75B	-61.47B	-76.08B	-92.19B
Common & Preferred Stock Dividends Paid	-46.72B	-49.75B	-61.47B	-76.08B	-92.19B
Other Financing Activities, Total	-32.4B	-34.79B	-50.31B	-53.59B	-54.73B
Cash from Financing	98.94B	-48.7B	-113B	-130B	-153B
Foreign Exchange Rate Adjustments	27.21B	41.54B	15B	42.75B	2.03B
Miscellaneous Cash Flow Adjustments	-59M	-1.59B	-570M	257M	-1.51B
Net Change in Cash	341B	55.54B	-170B	85.76B	24.1B
Supplemental Items
Cash Interest Paid	9.54B	8.84B	20.48B	44.62B	43.32B
Cash Income Tax Paid (Refund)	67.59B	96.74B	128B	139B	130B
Levered Free Cash Flow	215B	65.57B	-77.33B	78.13B	225B
Unlevered Free Cash Flow	221B	71.08B	-64.64B	106B	252B
Change In Net Working Capital	-42.86B	161B	307B	112B	-697M
Net Debt Issued / Repaid	178B	35.84B	-1.31B	52M	-6.55B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.05	5.6	5.8	5.34	5.01
Return on Total Capital	6.68	7.49	7.86	7.18	6.69
Return On Equity %	10.3	12.16	12.38	10.87	9.92
Return on Common Equity	10.07	11.96	12.24	10.67	9.72
Margin Analysis
Gross Profit Margin %	34.66	34.01	33.44	34.35	34.23
SG&A Margin	17.69	16.97	17.37	18.2	18.54
EBITDA Margin %	14.93	14.94	14.05	13.83	13.63
EBITA Margin %	10.78	11.23	10.46	9.96	9.47
EBIT Margin %	9.57	10.18	9.47	8.92	8.45
Income From Continuing Operations Margin %	6.53	7.25	6.67	6.14	5.8
Net Income Margin %	6.27	7	6.47	5.92	5.57
Net Avail. For Common Margin %	6.27	7	6.47	5.92	5.57
Normalized Net Income Margin	5.76	6.34	5.56	4.82	4.59
Levered Free Cash Flow Margin	8.63	2.11	-1.94	1.78	4.73
Unlevered Free Cash Flow Margin	8.85	2.29	-1.62	2.42	5.3
Asset Turnover
Asset Turnover	0.84	0.88	0.98	0.96	0.95
Fixed Assets Turnover	4.06	4.47	4.84	4.32	3.94
Receivables Turnover (Average Receivables)	5.63	6.02	6.29	5.94	5.84
Inventory Turnover (Average Inventory)	3.61	3.6	3.18	2.83	2.98
Short Term Liquidity
Current Ratio	2.26	1.66	1.67	1.74	1.85
Quick Ratio	1.56	1.07	0.9	0.98	1.06
Operating Cash Flow to Current Liabilities	0.49	0.19	0.11	0.25	0.33
Days Sales Outstanding (Average Receivables)	64.81	60.66	58	61.62	62.48
Days Outstanding Inventory (Average Inventory)	101.17	101.48	114.65	129.44	122.65
Average Days Payable Outstanding	45.99	43.11	40.24	42.24	40.12
Cash Conversion Cycle (Average Days)	119.98	119.03	132.41	148.81	145.01
Long Term Solvency
Total Debt/Equity	44.23	41.07	38.95	36.03	34.42
Total Debt / Total Capital	30.67	29.12	28.03	26.49	25.61
LT Debt/Equity	36.12	16.78	18.02	16.41	19.07
Long-Term Debt / Total Capital	25.05	11.9	12.97	12.06	14.19
Total Liabilities / Total Assets	47.57	47.49	47.04	44.93	44.16
EBIT / Interest Expense	27.14	35.85	18.58	8.73	9.33
EBITDA / Interest Expense	42.34	52.63	27.56	13.53	15.05
(EBITDA - Capex) / Interest Expense	30.4	39.7	18.93	8.13	9.34
Total Debt / EBITDA	2.02	1.78	1.59	1.59	1.52
Net Debt / EBITDA	0.04	0.02	0.48	0.38	0.28
Total Debt / (EBITDA - Capex)	2.81	2.35	2.31	2.65	2.46
Net Debt / (EBITDA - Capex)	0.06	0.02	0.7	0.63	0.46
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.23	24.69	28.06	10.39	8.12
Gross Profit, 1 Yr. Growth %	-2.35	22.36	25.93	13.38	7.75
EBITDA, 1 Yr. Growth %	-5.53	24.77	20.42	8.66	6.58
EBITA, 1 Yr. Growth %	-9.29	29.91	19.34	5.09	2.86
EBIT, 1 Yr. Growth %	-10.13	32.57	19.18	4.01	2.43
Earnings From Cont. Operations, 1 Yr. Growth %	-8.16	38.42	17.83	1.65	2.08
Net Income, 1 Yr. Growth %	-8.48	39.33	18.39	0.99	1.71
Normalized Net Income, 1 Yr. Growth %	-11.14	37.22	12.22	-4.15	2.97
Diluted EPS Before Extra, 1 Yr. Growth %	-8.5	39.31	18.37	0.98	1.69
Accounts Receivable, 1 Yr. Growth %	5.83	26.99	18.85	15.37	5.22
Inventory, 1 Yr. Growth %	8.21	43.05	47.94	5.47	0.49
Net Property, Plant and Equip., 1 Yr. Growth %	11.63	14.82	21.2	25.98	12.72
Total Assets, 1 Yr. Growth %	21.45	18.04	12.54	13.4	5.19
Tangible Book Value, 1 Yr. Growth %	25.81	23.91	13.33	23.92	10.73
Common Equity, 1 Yr. Growth %	16.07	18.26	13.48	18.01	6.22
Cash From Operations, 1 Yr. Growth %	24	-34.59	-35.16	151.46	28.75
Capital Expenditures, 1 Yr. Growth %	7.01	8.7	53.43	38.59	1.38
Levered Free Cash Flow, 1 Yr. Growth %	8.46	-69.52	-217.94	-201.04	187.82
Unlevered Free Cash Flow, 1 Yr. Growth %	7.5	-67.78	-190.94	-264.28	137.09
Dividend Per Share, 1 Yr. Growth %	0	25	20	4.17	12
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.25	10.41	26.37	18.9	9.25
Gross Profit, 2 Yr. CAGR %	-0.28	9.31	24.13	19.49	10.53
EBITDA, 2 Yr. CAGR %	-0.45	8.57	22.58	14.39	7.62
EBITA, 2 Yr. CAGR %	-5.87	8.55	24.51	11.99	3.97
EBIT, 2 Yr. CAGR %	-7.06	9.15	25.7	11.34	3.22
Earnings From Cont. Operations, 2 Yr. CAGR %	-8.8	12.75	27.71	9.45	1.87
Net Income, 2 Yr. CAGR %	-9.09	12.92	28.44	9.35	1.35
Normalized Net Income, 2 Yr. CAGR %	-7.13	10.42	24.09	3.71	-0.65
Diluted EPS Before Extra, 2 Yr. CAGR %	-9.11	12.9	28.42	9.33	1.33
Accounts Receivable, 2 Yr. CAGR %	1.87	15.93	22.86	17.1	10.18
Inventory, 2 Yr. CAGR %	3.72	24.42	45.48	24.92	2.95
Net Property, Plant and Equip., 2 Yr. CAGR %	15.78	13.21	17.97	23.56	19.16
Total Assets, 2 Yr. CAGR %	9.52	19.73	15.26	12.97	9.22
Tangible Book Value, 2 Yr. CAGR %	18.61	24.86	18.5	18.51	17.14
Common Equity, 2 Yr. CAGR %	8.46	17.16	15.85	15.73	11.96
Cash From Operations, 2 Yr. CAGR %	22.42	-9.94	-34.88	27.69	79.93
Capital Expenditures, 2 Yr. CAGR %	10.81	7.85	29.15	45.82	18.53
Levered Free Cash Flow, 2 Yr. CAGR %	27.45	-42.51	-40.05	9.16	70.53
Unlevered Free Cash Flow, 2 Yr. CAGR %	25.6	-41.15	-45.87	22.23	97.35
Dividend Per Share, 2 Yr. CAGR %	0	11.8	22.47	11.8	8.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.87	7.81	16.01	20.8	15.19
Gross Profit, 3 Yr. CAGR %	2.65	6.76	14.59	20.44	15.44
EBITDA, 3 Yr. CAGR %	2.21	7.33	12.38	17.75	11.73
EBITA, 3 Yr. CAGR %	-1.59	4.8	12.04	17.67	8.86
EBIT, 3 Yr. CAGR %	-2.03	4.62	12.4	18.01	8.28
Earnings From Cont. Operations, 3 Yr. CAGR %	-5.84	4.81	14.42	18.36	6.93
Net Income, 3 Yr. CAGR %	-6.15	4.82	14.72	18.55	6.74
Normalized Net Income, 3 Yr. CAGR %	-2.18	5.78	11.02	13.86	3.47
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.17	4.8	14.7	18.53	6.72
Accounts Receivable, 3 Yr. CAGR %	5.08	9.64	16.89	20.31	13
Inventory, 3 Yr. CAGR %	6.62	15.45	31.81	30.69	16.18
Net Property, Plant and Equip., 3 Yr. CAGR %	12.49	15.46	15.81	20.58	19.84
Total Assets, 3 Yr. CAGR %	9.17	12.29	17.29	14.63	10.31
Tangible Book Value, 3 Yr. CAGR %	12.89	20.35	20.89	20.28	15.85
Common Equity, 3 Yr. CAGR %	8.71	11.63	15.92	16.56	12.46
Cash From Operations, 3 Yr. CAGR %	18.75	-0.66	-19.28	2.17	28.04
Capital Expenditures, 3 Yr. CAGR %	7	10.1	21.3	32.22	29.18
Levered Free Cash Flow, 3 Yr. CAGR %	24.01	-20.89	-26.95	-28.65	50.81
Unlevered Free Cash Flow, 3 Yr. CAGR %	22.69	-20.2	-31.96	-21.63	52.43
Dividend Per Share, 3 Yr. CAGR %	4.55	7.72	14.47	16.04	11.87
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.06	8.75	11.69	12.12	13.26
Gross Profit, 5 Yr. CAGR %	3.96	7.66	10.76	11.68	12.95
EBITDA, 5 Yr. CAGR %	4.26	8.02	9.92	10.1	10.45
EBITA, 5 Yr. CAGR %	1.93	6.35	8.12	7.62	8.74
EBIT, 5 Yr. CAGR %	1.84	6.51	8.24	7.26	8.63
Earnings From Cont. Operations, 5 Yr. CAGR %	2.75	7.09	6.37	6.64	9.22
Net Income, 5 Yr. CAGR %	2.67	7.18	6.4	6.61	9.17
Normalized Net Income, 5 Yr. CAGR %	2.68	7.33	7.58	4.95	6.19
Diluted EPS Before Extra, 5 Yr. CAGR %	2.62	7.15	6.38	6.59	9.15
Accounts Receivable, 5 Yr. CAGR %	5.44	9.89	11.86	12.56	14.16
Inventory, 5 Yr. CAGR %	7.07	13.38	20.73	19.15	19.4
Net Property, Plant and Equip., 5 Yr. CAGR %	10.95	11.86	14.65	18.64	17.14
Total Assets, 5 Yr. CAGR %	8.14	10.17	11.57	12.56	13.99
Tangible Book Value, 5 Yr. CAGR %	17.76	19.34	15.1	19.61	19.37
Common Equity, 5 Yr. CAGR %	10.43	12.13	11.51	13.25	14.32
Cash From Operations, 5 Yr. CAGR %	10.62	-1.75	-6.62	9.83	11.23
Capital Expenditures, 5 Yr. CAGR %	1.66	5.25	15.36	23.2	20.19
Levered Free Cash Flow, 5 Yr. CAGR %	8.09	-15.29	-7.27	-10.02	2.54
Unlevered Free Cash Flow, 5 Yr. CAGR %	7.86	-14.61	-11.56	-5.36	4.17
Dividend Per Share, 5 Yr. CAGR %	5.92	9	11.38	9.34	11.84